Rydzewska-Rosołowska Alicja, Hryszko Tomasz
2 Department of Nephrology, Hypertension, and Internal Medicine with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.
Prz Gastroenterol. 2023;18(4):368-372. doi: 10.5114/pg.2023.133516. Epub 2023 Dec 8.
Fabry disease is a rare, X-linked metabolic error caused by various mutations in the α-galactosidase A gene, which results in the accumulation of glycosphingolipids. Gastrointestinal symptoms are quite common in affected patients; therefore, it is important for gastroenterologists to keep it in mind as a differential diagnosis for especially challenging patients. The following review provides concise information on epidemiology and genetics, signs, and symptoms of the disease, focusing on the gastrointestinal (GI) tract, providing a brief overview of the diagnostic process and the available treatment, both disease specific and supportive, again with a focus on alleviation of gastrointestinal symptoms.
法布里病是一种罕见的X连锁代谢紊乱疾病,由α-半乳糖苷酶A基因的各种突变引起,导致糖鞘脂蓄积。胃肠道症状在受影响的患者中相当常见;因此,对于胃肠病学家来说,将其作为特别具有挑战性患者的鉴别诊断疾病牢记于心很重要。以下综述提供了关于该疾病的流行病学、遗传学、体征和症状的简明信息,重点关注胃肠道,简要概述了诊断过程以及可用的疾病特异性和支持性治疗,同样重点是缓解胃肠道症状。